VAXART INC WKN: A2JD8X ISIN: US92243A2006 Kürzel: VXRT Forum: Aktien Thema: Hauptdiskussion

Und dann ins Minus drehen

Wie kann man denn 30% Plus verspielen 🤯

Amis sind confused was wir hier in DE machen

Schade

Die springen alle bei Ocugen mit auf, vermutlich 🤷‍♂️

Bei 7,5€ (ca. 9$) steht mein Körbchen bereit

Keine Panik auf Titanik

Von 12.50auf unter 9😵

Puhhh

Ich weiss nicht was waren die Analystenerwartungen

Wenn man q1 2020 und 2021 vergleicht, natürlich sind mehr Verluste drin

Vaxart ended the quarter with cash, cash equivalents, and available-for-sale debt securities of $177.3 million, compared to $126.9 million as of December 31, 2020. The increase was primarily due to receipts of $65.7 million from the Company’s $250 million at-the-market facility entered into in October 2020 and $1.9 million from the exercise of warrants and options, partially offset by $16.6 million of cash used in operations and $0.6 million spent on property and equipment. Financial Results for the Three Months Ended March 31, 2021: Vaxart reported a net loss of $16.0 million for the first quarter of 2021 compared to $1.3 million for the first quarter of 2020. Net loss per share for the first quarter of 2021 was $0.14, compared to a net loss of $0.02 in the first quarter of 2020. The increase in net loss per share was due to the increase in net loss partially offset by the increase in the weighted average number of shares outstanding. Revenue for the first quarter of 2021 was $506,000 compared to $2.9 million in the first quarter of 2020. The decrease was principally due to a reduction in royalty revenue related to Inavir sales in Japan as a result of abnormally low incidences of seasonal influenza. Research and development expenses were $10.1 million for the first quarter of 2021 compared to $1.5 million for the first quarter of 2020. The increase was mainly due to manufacturing and clinical trial expenses related to the COVID-19 and norovirus vaccine candidates. General and administrative expenses were $5.9 million for the first quarter of 2021 compared to $2.0 million for the first quarter of 2020. The increase was mainly due to higher legal and insurance expenses, and an increase in headcount and related costs.

und eben den dip genutzt um nochmal bisschen nachzukaufen :-), hoffentlich geht die Rechnung auf

Sind die news gut oxa? Hab grad leider nicht die zeit mir das genau durchzulesen.

Manno man, Achterbahn 🎢 ist ja gar nichts dagegen 😅👍

Find ich super. Von mir aus gerbe bis 15:30 so haben die Amis dann die besten vorraussetzungen wieder 30%+ zu machen